Hamamelis Vir
Over-the-Counterالأسماء التجارية: HAMAMELIS VIR
About This Medication
Oral preparation used for symptom management and health support.
المواد الفعالة
| المادة الفعالة | التركيز |
|---|---|
| Hamamelis Virginiana Root Bark/Stem Bark | - |
المؤشرات العلاجية والاستخدام
الجرعة وطريقة الإعطاء
التحذيرات والاحتياطات
WARNINGS This product is to be used for self-limiting conditions If symptoms do not improve in 4 days, or worsen, discontinue use and seek assistance of health professional As with any drug, if you are pregnant, or nursing a baby, seek professional advice before taking this product Keep this and all medication out of reach of children Do not use if capseal is broken or missing. Close the cap tightly after use.
Frequently Asked Questions
INDICATIONS Condition listed above or as directed by the physician
DOSAGE Adults: Mix 4-6 drops in 1/2 cup of water, take orally three times daily or as directed by a physician. Children (2 years and older): Take half the adult dose.
WARNINGS This product is to be used for self-limiting conditions If symptoms do not improve in 4 days, or worsen, discontinue use and seek assistance of health professional As with any drug, if you are pregnant, or nursing a baby, seek professional advice before taking this product Keep this and all medication out of reach of children Do not use if capseal is broken or missing. Close the cap tightly after use.
Hamamelis Vir is available over the counter (OTC) without a prescription.
Similar Tablet Products
Browse all Tablet products →References & Data Sources
- • DailyMed — Hamamelis Vir drug label (National Library of Medicine)
- • openFDA — Hamamelis Vir label data (U.S. Food & Drug Administration)
- • NDC Directory — Hamamelis Vir (FDA National Drug Code)
إخلاء المسؤولية الطبية
المعلومات الواردة في هذه الصفحة مخصصة للأغراض التعليمية فقط ولا ينبغي استخدامها بديلًا عن المشورة الطبية المتخصصة أو التشخيص أو العلاج.
استشر دائمًا طبيبك أو أي مقدم رعاية صحية مؤهل بشأن أي أسئلة تتعلق بحالة طبية أو دواء.
مصادر البيانات: DailyMed (NLM), openFDA, MFDS